Neck News and Research

RSS

Lower levels of protein make squamous carcinoma cells more invasive

Loss of a protein called TRIM29 promotes cancer cell invasion in a common type of skin cancer, suggesting a novel diagnostic marker and a possible therapeutic target.

21 Nov 2018

Towards finding a druggable cancer target

It's known that cancer involves unchecked cell growth and that a biological pathway that regulates organ size, known at the Hippo pathway, is also involved in cancer.

19 Nov 2018

Researchers evaluate efficacy of salivary biomarkers for early detection of oral cancer

Over 90% of malign tumors in the head and neck are originated from carcinomas of squamous cells that appear in superficial areas of the oral cavity. Their detection with salivary biomarkers can contribute to their early treatment, before they transform into tumors.

14 Nov 2018

Survey: Complementary and alternative medicine is widely used by general population in England

Use of practitioner-led complementary and alternative medicine (CAM), such as acupuncture, massage, osteopathy and chiropractic treatment, rose from 12 per cent of the population in 2005 to 16 per cent of the population in 2015, according to a survey led by researchers at the University of Bristol's Centre for Academic Primary Care.

14 Nov 2018

Neck scan detects dementia way before symptoms appear

Researchers have shown that early dementia signs could be detected by a simple short scan of the individual’s neck. The actual dementia symptoms could be seen up to 10 years after these signs are visible on the scans they add. If proven robust for all cases, this test could soon become routine for screening middle aged individuals and classifying them as high risk for dementia later in life.

11 Nov 2018

Potential treatment for rare polio-like illness shows no signal of efficacy

Researchers have been searching for possible treatments for the polio-like illness causing paralysis in children, called acute flaccid myelitis.

9 Nov 2018

Study: 'Adam's apple' reduction surgery has high patient satisfaction rates

Cosmetic surgery to reduce the masculine appearance of the "Adam's apple" has a high patient satisfaction rate, according to a study in Plastic and Reconstructive Surgery--Global Open®, the official open-access medical journal of the American Society of Plastic Surgeons.

8 Nov 2018

Nasal delivery of leptin hormone may help ease breathing problems during sleep

Experimenting with mice, Johns Hopkins Medicine researchers have added to evidence that a hormone best known for helping regulate hunger and body weight might also ease breathing problems experienced during sleep more effectively when given through the nose.

7 Nov 2018

Low risk thyroid cancer patients can be treated with smaller amount of radiation, suggests study

Thyroid cancer patients whose disease is at low risk of returning can be treated safely with a smaller amount of radiation following surgery, according to results from the world's longest running trial to investigate this.

5 Nov 2018

Routine mouth cancer screens could save lives

The Head and Neck Cancer Foundation is calling all Brits to ask their dentists to conduct mouth cancer screens at their next appointment. This should be routinely included within the price of a dental check-up and should take no more than one minute.

2 Nov 2018

NEC and Transgene sign MOU for strategic collaboration aimed at treating solid cancers

NEC Corporation and Transgene today announced the signing of a Memorandum of Understanding for a strategic collaboration aimed at the treatment of solid cancers.

30 Oct 2018

Head and neck cancer survivors more likely to commit suicide

Despite improved survival rates among cancer patients, the risk of death by suicide remains high, especially among those treated for head and neck cancers.

25 Oct 2018

How to avoid shoulder injury related to vaccine administration

A study by researchers at the University of Waterloo reiterates the need for health care professionals, including pharmacists, to take certain precautions to minimize the risk of their patients suffering shoulder injury related to vaccine administration

24 Oct 2018

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell carcinoma are free from cancer following radiation therapy.

23 Oct 2018

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

A new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked head and neck cancer patients to ensure they remain cancer-free after treatment.

23 Oct 2018

Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer

Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a major phase III clinical trial.

23 Oct 2018

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

With a pair of RO1 grants from the National Institutes of Health, pain researcher Daniela Salvemini, Ph.D., will embark on two new research projects, studying chemotherapy-induced cognitive impairment, or "chemo brain," symptoms and unwanted side effects of opioids.

23 Oct 2018

Cancer treatment may undergo a paradigm shift to immunotherapy soon

Immunotherapy when used for cancer treatment could extend life longer finds studies. Experts have explained that until now immunotherapy was reserved as a last resort for most patients and treatment usually comprised of chemotherapy and radiation therapy failing which these were tried. In a pair of clinical trials, researchers have found that using immunotherapy as first line treatment can extend lives of these cancer patients.

23 Oct 2018

Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer

Immunotherapy with pembrolizumab improves survival in patients with head and neck cancer that has recurred or metastasized, according to late-breaking results from the KEYNOTE-048 study reported at the ESMO 2018 Congress in Munich.

22 Oct 2018

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.

22 Oct 2018

Neck News and Research

Lower levels of protein make squamous carcinoma cells more invasive

Towards finding a druggable cancer target

Researchers evaluate efficacy of salivary biomarkers for early detection of oral cancer

Survey: Complementary and alternative medicine is widely used by general population in England

Neck scan detects dementia way before symptoms appear

Potential treatment for rare polio-like illness shows no signal of efficacy

Study: 'Adam's apple' reduction surgery has high patient satisfaction rates

Nasal delivery of leptin hormone may help ease breathing problems during sleep

Low risk thyroid cancer patients can be treated with smaller amount of radiation, suggests study

Routine mouth cancer screens could save lives

NEC and Transgene sign MOU for strategic collaboration aimed at treating solid cancers

Head and neck cancer survivors more likely to commit suicide

How to avoid shoulder injury related to vaccine administration

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

Cancer treatment may undergo a paradigm shift to immunotherapy soon

Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News